153 related articles for article (PubMed ID: 25343299)
21. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes.
Guo Z; Raeissi S; White RB; Stevens JC
Drug Metab Dispos; 1997 Mar; 25(3):390-3. PubMed ID: 9172960
[TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
McCormick A; Swaisland H; Reddy VP; Learoyd M; Scarfe G
Xenobiotica; 2018 Jun; 48(6):555-564. PubMed ID: 28657402
[TBL] [Abstract][Full Text] [Related]
23. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
Kahma H; Aurinsalo L; Neuvonen M; Katajamäki J; Paludetto MN; Viinamäki J; Launiainen T; Filppula AM; Tornio A; Niemi M; Backman JT
Eur J Pharm Sci; 2021 Jul; 162():105810. PubMed ID: 33753217
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes.
Lee SY; Jang H; Lee JY; Ma JY; Oh SJ; Kim SK
Xenobiotica; 2015 Feb; 45(2):131-8. PubMed ID: 25145883
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
Kim KA; Park JY
Drug Metab Dispos; 2003 Sep; 31(9):1090-2. PubMed ID: 12920163
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes.
Nakamura K; Ariyoshi N; Iwatsubo T; Fukunaga Y; Higuchi S; Itoh K; Shimada N; Nagashima K; Yokoi T; Yamamoto K; Horiuchi R; Kamataki T
Biol Pharm Bull; 2005 May; 28(5):882-5. PubMed ID: 15863898
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
[TBL] [Abstract][Full Text] [Related]
28. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
[TBL] [Abstract][Full Text] [Related]
30. Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.
Oganesian A; Shilling AD; Young-Sciame R; Tran J; Watanyar A; Azam F; Kao J; Leung L
Psychopharmacol Bull; 2009; 42(2):47-63. PubMed ID: 19629022
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.
Ohyama K; Nakajima M; Suzuki M; Shimada N; Yamazaki H; Yokoi T
Br J Clin Pharmacol; 2000 Mar; 49(3):244-53. PubMed ID: 10718780
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes.
Shimokawa Y; Yoda N; Kondo S; Yamamura Y; Takiguchi Y; Umehara K
Biol Pharm Bull; 2015; 38(9):1425-9. PubMed ID: 26094899
[TBL] [Abstract][Full Text] [Related]
33. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
Ramírez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ
Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333
[TBL] [Abstract][Full Text] [Related]
34. Potent inhibitory effect of alpha-viniferin on human cytochrome P450.
Sim J; Jang HW; Song M; Kim JH; Lee SH; Lee S
Food Chem Toxicol; 2014 Jul; 69():276-80. PubMed ID: 24769006
[TBL] [Abstract][Full Text] [Related]
35. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
Wei J; Zhang H; Zhao Q
Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
[TBL] [Abstract][Full Text] [Related]
36. Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes.
Umehara K; Shimokawa Y; Miyamoto G
Biol Pharm Bull; 2004 Jul; 27(7):1151-3. PubMed ID: 15256760
[TBL] [Abstract][Full Text] [Related]
37. Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities.
Kopečná-Zapletalová M; Krasulová K; Anzenbacher P; Hodek P; Anzenbacherová E
Xenobiotica; 2017 Apr; 47(4):324-331. PubMed ID: 27312150
[TBL] [Abstract][Full Text] [Related]
38. Interaction of antitumor platinum complexes with human liver microsomal cytochromes P450.
Masek V; Anzenbacherová E; Machová M; Brabec V; Anzenbacher P
Anticancer Drugs; 2009 Jun; 20(5):305-11. PubMed ID: 19378397
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
40. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]